TRPC5OS

Chr X

TRPC5 opposite strand

Also known as: TRPC5-AS1

I cannot provide a clinical summary for TRPC5OS as no supporting data about this gene's protein function, associated diseases, or inheritance patterns has been provided. Clinical gene summaries require specific evidence about the gene's role in human disease to ensure accuracy for clinical decision-making.

Multiplemechanism

Population Genetics & Constraint

Constraint data not available from gnomAD.

DN
0.81top 10%
GOF
0.72top 25%
LOF
0.2092th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TRPC5OS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →